Home » Products » Cancer Immunotherapy: Tumor Microenvironment
Cancer Immunotherapy: Tumor Microenvironment
A large body of evidence suggests that tumors create an immunosuppressive microenvironment that inhibits the immune system’s natural ability to recognize and destroy tumor cells. This is accomplished via several mechanisms, including the recruitment of immunosuppressive cells, activation of immune checkpoint pathways, and exclusion of T cells. Gaining a better understanding of these immunosuppressive mechanisms will provide an important step towards developing novel strategies to overcome this obstacle to cancer immunotherapies. Trust the products and services offered by R&D Systems, your leading provider of immunology reagents, to investigate the immunosuppressive tumor microenvironment. Click the links below to learn more and find the products you are looking for.